Economy
-
-
WisdomTree Europe Quality Dividend Growth Fund declares quarterly distribution of $0.0450
-
New York and New Jersey declare states of emergency, bracing for flooding and outages from nor’easter
-
How ‘Ozempic face’ is pushing Gen X, already the biggest Botox and filler consumers, to the facelift table a decade early
As the “forgotten generation” squashed between the culturally dominant Boomers and millennials, the people born between the late 60s and 80s often go under the radar in conversations about Botox online. But that generation is now arriving at plastic surgeons’ offices not just for wrinkle treatments, but for facelifts once reserved for patients 15 years…
-
35% of bettors are leaving sportsbooks for prediction markets, echoing the regulatory loophole DraftKings built its business on
In 2006 Congress passed a law called the Unlawful Internet Gambling Enforcement Act, which didn’t ban online betting but rather, banned banks from processing payments for it. It carved out one exception: fantasy sports, because Congress considered it a game of skill, not a game of chance like betting on a single game is. And…
-
Temu spent up to $962 million on ads that helped finance an army of fake creators on Meta platforms, research claims
If you are one of Ya Lili’s 183,000 followers on her “@findgadgetswithme” Instagram account, you may have seen this video she posted recently: A man stands on a sunny beach, dressed only in swim shorts, his back covered in dirt. “This won’t come off!” he shouts as he rubs futilely at the brown filth covering…
-
GLP-1 drugs like Wegovy are all the rage—but people are quitting them too fast to achieve meaningful weight loss, finds 170,000-patient study
As recently as the onset of COVID-19 four years ago, you probably didn’t know what a glucagon-like peptide 1 agonist, or GLP-1 drug, was. But this class of medications, which help people with Type 2 diabetes and obesity lower their blood sugar and promote weight loss, is now a household name. “It’s everywhere,” Dr. Razia…
-
‘Our industry sees the risks and is concerned’: European tech leaders join calls for AI slowdown
European tech leaders have lent their support to calls to slow down AI advancement, following warnings that the technology poses an existential threat to humanity. “Slowing the pace of this technology is important, but it needs to be [regulated] across governments, and we need enforcement across countries for it to work,” said Pip White, head…
-
Quantum won’t kill crypto—but it could accelerate Wall Street’s adoption of blockchain
For many in the crypto industry, the specter of quantum computing has become the stuff of existential dread. According to popular doomer narratives, public blockchains like Bitcoin will be among the first target of quantum-based attacks that will wipe out trillions of dollars. In this view, public blockchains most salient feature, decentralization, is an Achilles…
-
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
GLP-1s, or glucagon-like peptide-1 agonist drugs, are seemingly everywhere. In recent years, this class of weight-loss and Type 2 diabetes medication has become not only a household name but inescapable. Shortages have dominated news headlines, and singsong commercials about the best online GLP-1 programs have taken over airwaves. GLP-1s have gone so far as to…